These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Use of prostaglandin E1 for emergency palliation of symptomatic coarctation of the Aorta. Graham TP, Atwood GF, Boucek RJ. Cathet Cardiovasc Diagn; 1978; 4(1):97-102. PubMed ID: 77192 [Abstract] [Full Text] [Related]
7. Efficacy of prostaglandin E1 in relieving obstruction in coarctation of a persistent fifth aortic arch without opening the ductus arteriosus. Carroll SJ, Ferris A, Chen J, Liberman L. Pediatr Cardiol; 2006; 27(6):766-8. PubMed ID: 17111291 [Abstract] [Full Text] [Related]
8. Pharmacologic use of prostaglandin E1 in infant with congenital heart disease. Heymann MA. Am Heart J; 1981 Jun; 101(6):837-43. PubMed ID: 7234660 [No Abstract] [Full Text] [Related]
9. Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies. Gittenberger-de Groot AC, Moulaert AJ, Harinck E, Becker AE. Br Heart J; 1978 Mar; 40(3):215-20. PubMed ID: 637973 [Abstract] [Full Text] [Related]
10. Use of prostaglandin E1 for maintaining the patency of the ductus arteriosus. Noah ML. Adv Prostaglandin Thromboxane Res; 1978 Mar; 4():355-62. PubMed ID: 347914 [Abstract] [Full Text] [Related]
11. [Prostaglandin E1. Emergency therapy in infants with preductal coarctation of the aorta (author's transl)]. Schöber JG, Kellner M. Monatsschr Kinderheilkd (1902); 1979 Oct; 127(10):617-20. PubMed ID: 492181 [Abstract] [Full Text] [Related]
12. Pathology of the ductus arteriosus treated with prostaglandins: comparisons with untreated cases. Calder AL, Kirker JA, Neutze JM, Starling MB. Pediatr Cardiol; 1984 Oct; 5(2):85-92. PubMed ID: 6591146 [Abstract] [Full Text] [Related]
13. Indomethacin induced and prostaglandin relieved coarctation of the aorta in right aortic arch with left arterial duct: a case report. Golden-Plotnik S, Rosenberg HC, Altamirano-Diaz LA. Cardiol Young; 2017 Jul; 27(5):1026-1029. PubMed ID: 28260552 [Abstract] [Full Text] [Related]
14. Management of aortic arch interruption with prostaglandin E1 infusion and microporous expanded polytetrafluoroethylene grafts. Zahka KG, Roland JM, Cutilletta AF, Gardner TJ, Donahoo JS, Kidd L. Am J Cardiol; 1980 Dec 01; 46(6):1001-5. PubMed ID: 7446413 [Abstract] [Full Text] [Related]
16. Pharmacologic dilatation of the ductus arteriosus with prostaglandin E1 in infants with congenital heart disease. Graham TP, Atwood GF, Boucek RJ. South Med J; 1978 Oct 10; 71(10):1238-41, 1246. PubMed ID: 81528 [Abstract] [Full Text] [Related]
17. The morphology of the human newborn ductus arteriosus: a reappraisal of its structure and closure with special reference to prostaglandin E1 therapy. Silver MM, Freedom RM, Silver MD, Olley PM. Hum Pathol; 1981 Dec 10; 12(12):1123-36. PubMed ID: 7199511 [Abstract] [Full Text] [Related]
18. Prostaglandin E1 infusion in the hypoplastic left heart syndrome. Yabek SM, Mann JS. Chest; 1979 Sep 10; 76(3):330-1. PubMed ID: 467122 [Abstract] [Full Text] [Related]
19. Prostaglandin E1 infusion: successful initial treatment. Linday L, Levin AR, Reitman M, Engle MA. N Y State J Med; 1981 Feb 10; 81(2):218-21. PubMed ID: 6936640 [No Abstract] [Full Text] [Related]
20. Role of prostaglandin E1 and E2 in the management of neonatal heart disease. Olley PM, Coceani F, Rowe RD. Adv Prostaglandin Thromboxane Res; 1978 Feb 10; 4():345-53. PubMed ID: 645511 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]